Cambridge Advisors Lowers stake in Danaher Corporation (DHR)

Danaher Corporation (DHR) : Cambridge Advisors reduced its stake in Danaher Corporation by 0.71% during the most recent quarter end. The investment management company now holds a total of 20,776 shares of Danaher Corporation which is valued at $1,679,740 after selling 149 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Danaher Corporation makes up approximately 0.75% of Cambridge Advisors’s portfolio.

Other Hedge Funds, Including , Calamos Advisors boosted its stake in DHR in the latest quarter, The investment management firm added 25 additional shares and now holds a total of 65,642 shares of Danaher Corporation which is valued at $5,307,156. Danaher Corporation makes up approx 0.05% of Calamos Advisors’s portfolio.Pioneer Trust Bank N Aor reduced its stake in DHR by selling 15 shares or 0.03% in the most recent quarter. The Hedge Fund company now holds 46,243 shares of DHR which is valued at $3,742,908. Danaher Corporation makes up approx 2.21% of Pioneer Trust Bank N Aor’s portfolio.Cue Financial Group reduced its stake in DHR by selling 1,290 shares or 4.7% in the most recent quarter. The Hedge Fund company now holds 26,133 shares of DHR which is valued at $2,117,818. Danaher Corporation makes up approx 1.77% of Cue Financial Group’s portfolio.

Danaher Corporation opened for trading at $81.32 and hit $81.76 on the upside on Friday, eventually ending the session at $81.44, with a gain of 0.32% or 0.26 points. The heightened volatility saw the trading volume jump to 34,28,543 shares. Company has a market cap of $56,237 M.

On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.

Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.